Article PDF
Avoid common mistakes on your manuscript.
References
McCowen KC, Malhotra A, Bistrian BR. Endocrine and metabolic dysfunction syndromes in the critically ill. Crit Care Clin 2001; 17: 107–24.
Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359–67.
Vanhorebeek I, Langouche L, Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11: 304–11.
Van den Berghe G, Wouters PJ, Bouilllon R, et al. Outcome benefit of intensive insulin therapy in critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31: 359–66.
Langouche L, Van den Berghe G. Glucose metabolism and insulin therapy. Crit Care Clin 2006; 22: 119–29.
Malhotra A. Intensive insulin in intensive care (Editorial). N Engl J Med 2006; 354: 516–7.
Angus DC, Abraham E. Intensive insulin therapy in critical illness (Editorial). Am J Resp Crit Care Med 2005; 172: 1358–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brindley, P.G., Paton-Gay, D. Best evidence in critical care medicine. Can J Anesth 53, 947–949 (2006). https://doi.org/10.1007/BF03022838
Issue Date:
DOI: https://doi.org/10.1007/BF03022838